Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

treosulfan × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 16 Myeloid 10 Lymphoid 6 Thoracic 1 Sarcoma 1 Plasma cell 1 Gynecologic 1 Dermatologic 1 Classical hematology 1

Conditions

Neoplasm Metastasis 1 Melanoma 1

Interventions

pembrolizumab 290 Nivolumab 259 Ipilimumab 232 Cyclophosphamide 170 aldesleukin 130 Interleukin-2 93 fludarabine phosphate 89 trametinib 78 fludarabine 73 dabrafenib 68 Radiotherapy 67 Dacarbazine 66 Temozolomide 65 Biopsy 63 Vemurafenib 61 Imiquimod 48 Radiosurgery 47 Bevacizumab 46 Magnetic Resonance Spectroscopy 44 sargramostim 43 Blood Specimen Collection 42 Aminolevulinic Acid 42 3-ingenyl angelate 42 Specimen Handling 41 Peripheral Blood Stem Cell Transplantation 40 Paclitaxel 39 Cisplatin 39 cemiplimab 38 Carboplatin 37 atezolizumab 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡